A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS INJECTIONS OF SHR-1819 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Clinical trial NCT05197023 · UNKNOWN
Trial details
- NCT number
- NCT05197023
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2022-06-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.